|
Volumn 6, Issue 3, 2002, Pages 271-274
|
What are the challenges of translating positive trial results in severe sepsis into clinical practice? A media roundtable debate, 18 March 2002, Brussels, Belgium
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACTIVATED PROTEIN C;
AWARENESS;
BELGIUM;
BLOOD GLUCOSE MONITORING;
CLINICAL FEATURE;
CLINICAL PRACTICE;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
CRITICAL ILLNESS;
DISEASE PREDISPOSITION;
DISEASE SEVERITY;
DRUG COST;
DRUG USE;
EARLY DIAGNOSIS;
FATALITY;
HEALTH CARE PERSONNEL;
HUMAN;
INCIDENCE;
INFECTION;
INFLAMMATION;
INTENSIVE CARE;
MEDICAL RESEARCH;
PATIENT CARE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SEPSIS;
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;
CLINICAL TRIALS;
CLINICAL TRIALS AS TOPIC;
DIFFUSION OF INNOVATION;
PROTEIN C;
RECOMBINANT PROTEINS;
SEPSIS;
SUPPORT, NON-U.S. GOV'T;
|
EID: 0035998351
PISSN: 13648535
EISSN: None
Source Type: Journal
DOI: 10.1186/cc1503 Document Type: Conference Paper |
Times cited : (3)
|
References (19)
|